QQQ   312.40 (-0.62%)
AAPL   127.68 (-0.95%)
MSFT   213.83 (+0.38%)
FB   251.42 (+2.35%)
GOOGL   1,739.00 (+0.47%)
AMZN   3,107.42 (-0.64%)
TSLA   821.41 (-2.79%)
NVDA   518.81 (-1.74%)
BABA   242.94 (-0.02%)
CGC   33.84 (-2.25%)
GE   11.41 (-2.14%)
MU   81.10 (-0.25%)
AMD   88.95 (-2.03%)
T   29.19 (-0.34%)
NIO   56.59 (-7.03%)
F   9.94 (-2.26%)
ACB   12.06 (+0.84%)
BA   205.23 (-2.23%)
DIS   171.53 (-1.10%)
NFLX   500.14 (-0.14%)
GILD   63.32 (+1.47%)
QQQ   312.40 (-0.62%)
AAPL   127.68 (-0.95%)
MSFT   213.83 (+0.38%)
FB   251.42 (+2.35%)
GOOGL   1,739.00 (+0.47%)
AMZN   3,107.42 (-0.64%)
TSLA   821.41 (-2.79%)
NVDA   518.81 (-1.74%)
BABA   242.94 (-0.02%)
CGC   33.84 (-2.25%)
GE   11.41 (-2.14%)
MU   81.10 (-0.25%)
AMD   88.95 (-2.03%)
T   29.19 (-0.34%)
NIO   56.59 (-7.03%)
F   9.94 (-2.26%)
ACB   12.06 (+0.84%)
BA   205.23 (-2.23%)
DIS   171.53 (-1.10%)
NFLX   500.14 (-0.14%)
GILD   63.32 (+1.47%)
QQQ   312.40 (-0.62%)
AAPL   127.68 (-0.95%)
MSFT   213.83 (+0.38%)
FB   251.42 (+2.35%)
GOOGL   1,739.00 (+0.47%)
AMZN   3,107.42 (-0.64%)
TSLA   821.41 (-2.79%)
NVDA   518.81 (-1.74%)
BABA   242.94 (-0.02%)
CGC   33.84 (-2.25%)
GE   11.41 (-2.14%)
MU   81.10 (-0.25%)
AMD   88.95 (-2.03%)
T   29.19 (-0.34%)
NIO   56.59 (-7.03%)
F   9.94 (-2.26%)
ACB   12.06 (+0.84%)
BA   205.23 (-2.23%)
DIS   171.53 (-1.10%)
NFLX   500.14 (-0.14%)
GILD   63.32 (+1.47%)
QQQ   312.40 (-0.62%)
AAPL   127.68 (-0.95%)
MSFT   213.83 (+0.38%)
FB   251.42 (+2.35%)
GOOGL   1,739.00 (+0.47%)
AMZN   3,107.42 (-0.64%)
TSLA   821.41 (-2.79%)
NVDA   518.81 (-1.74%)
BABA   242.94 (-0.02%)
CGC   33.84 (-2.25%)
GE   11.41 (-2.14%)
MU   81.10 (-0.25%)
AMD   88.95 (-2.03%)
T   29.19 (-0.34%)
NIO   56.59 (-7.03%)
F   9.94 (-2.26%)
ACB   12.06 (+0.84%)
BA   205.23 (-2.23%)
DIS   171.53 (-1.10%)
NFLX   500.14 (-0.14%)
GILD   63.32 (+1.47%)
Log in
NASDAQ:ICUI

ICU Medical Stock Forecast, Price & News

$215.49
-5.89 (-2.66 %)
(As of 01/15/2021 03:04 PM ET)
Add
Compare
Today's Range
$214.95
Now: $215.49
$222.78
50-Day Range
$184.92
MA: $205.73
$222.54
52-Week Range
$158.01
Now: $215.49
$236.51
Volume2,971 shs
Average Volume196,707 shs
Market Capitalization$4.52 billion
P/E Ratio57.01
Dividend YieldN/A
Beta0.72
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms, as well as related professional services. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
ICU Medical logo

MarketRank

Overall MarketRank

1.26 out of 5 stars

Medical Sector

627th out of 1,480 stocks

Surgical & Medical Instruments Industry

73rd out of 135 stocks

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ICUI
CUSIP44930G10
Phone949-366-2183
Employees8,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.27 billion
Cash Flow$11.49 per share
Book Value$66.62 per share

Profitability

Net Income$101.04 million

Miscellaneous

Market Cap$4.52 billion
Next Earnings Date2/25/2021 (Estimated)
OptionableOptionable
$215.49
-5.89 (-2.66 %)
(As of 01/15/2021 03:04 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

How has ICU Medical's stock price been impacted by Coronavirus (COVID-19)?

ICU Medical's stock was trading at $180.56 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ICUI stock has increased by 19.3% and is now trading at $215.49.
View which stocks have been most impacted by COVID-19
.

Is ICU Medical a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ICU Medical stock.
View analyst ratings for ICU Medical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than ICU Medical?

Wall Street analysts have given ICU Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ICU Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for ICU Medical
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) issued its quarterly earnings results on Thursday, November, 5th. The medical instruments supplier reported $1.90 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.31 by $0.59. The medical instruments supplier had revenue of $318.60 million for the quarter, compared to the consensus estimate of $291.37 million. ICU Medical had a return on equity of 9.73% and a net margin of 6.43%. The firm's revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.65 EPS.
View ICU Medical's earnings history
.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical issued an update on its FY 2020 After-Hours earnings guidance on Thursday, November, 5th. The company provided earnings per share (EPS) guidance of 6.65-7.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.40.

What price target have analysts set for ICUI?

3 equities research analysts have issued 12 month target prices for ICU Medical's shares. Their forecasts range from $210.00 to $236.00. On average, they expect ICU Medical's stock price to reach $223.00 in the next twelve months. This suggests a possible upside of 3.5% from the stock's current price.
View analysts' price targets for ICU Medical
or view Wall Street analyst' top-rated stocks.

Who are some of ICU Medical's key competitors?

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), The Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

Who are ICU Medical's key executives?

ICU Medical's management team includes the following people:
  • Mr. Vivek Jain, CEO & Chairman (Age 49, Pay $824.88k)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 53, Pay $495.38k)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel & Sec. (Age 45, Pay $402.38k)
  • Mr. Daniel Woolson, Corp. VP & GM of Infusion Systems (Age 44, Pay $402.38k)
  • Mr. Brian Michael Bonnell, CFO & Treasurer (Age 47)
  • Mr. Kevin J. McGrody, Chief Accounting Officer
  • Mr. Steven C. Riggs, Exec. Officer of Special Project Opertions (Age 62)

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Boston Trust Walden Corp (0.60%), Scout Investments Inc. (0.23%), Private Trust Co. NA (0.03%), State of Alaska Department of Revenue (0.02%), Crossmark Global Holdings Inc. (0.01%) and Raymond James Trust N.A. (0.01%). Company insiders that own ICU Medical stock include Christian B Voigtlander, Elisha W Finney, George A Lopez, Kevin J Mcgrody, Robert S Swinney, Scott E Lamb, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends for ICU Medical
.

Which major investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Crossmark Global Holdings Inc., State of Alaska Department of Revenue, and Raymond James Trust N.A.. Company insiders that have sold ICU Medical company stock in the last year include Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone, and Vivek Jain.
View insider buying and selling activity for ICU Medical
or view top insider-selling stocks.

Which major investors are buying ICU Medical stock?

ICUI stock was bought by a variety of institutional investors in the last quarter, including Scout Investments Inc., and Private Trust Co. NA.
View insider buying and selling activity for ICU Medical
or or view top insider-buying stocks.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $215.49.

How big of a company is ICU Medical?

ICU Medical has a market capitalization of $4.52 billion and generates $1.27 billion in revenue each year. The medical instruments supplier earns $101.04 million in net income (profit) each year or $7.36 on an earnings per share basis. ICU Medical employs 8,000 workers across the globe.

What is ICU Medical's official website?

The official website for ICU Medical is www.icumed.com.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]

This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.